---
figid: PMC9138354__biomolecules-12-00635-g001
figtitle: Synergistic Cooperation between TGFB and Hypoxia in Cancer and Fibrosis
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Gallus gallus
- Clostridium perfringens
pmcid: PMC9138354
filename: biomolecules-12-00635-g001.jpg
figlink: /pmc/articles/PMC9138354/figure/biomolecules-12-00635-f001/
number: F1
caption: (A) A graphical illustration of canonical (left) and non-canonical (right)
  TGF-β signaling. In canonical TGF-β signaling, TGF-β ligand binds to TGFβRI (TβRI)
  and TGFβRII (TβRII) receptors, resulting in their activation in a hetero-tetrameric
  complex. The intracellular Smad2/3 are next activated by phosphorylation, initiated
  by TGFβRI; pSmad2/3 form a complex with Smad4 and, together with certain transcription
  factors (TF), activate specific targets genes that contain Smad-binding elements
  (SBEs), implicated in growth inhibition, apoptosis, ECM synthesis, and immune response.
  In the non-canonical signaling pathway, TGF-β induces the expression of TRAF6 and
  ubiquitinates it in a Lys63-dependent manner, promoting its catalytic activity.
  TRAF6 then activates TACE and PSEN1, resulting in the proteolytic cleavage of TGFβRI,
  generating the soluble TGFβRI intracellular domain (TGFβRI-ICD/ TβRI-ICD). The endosomal
  adaptor proteins APPL1/APPL2 and intact microtubules are required for the translocation
  of TGFβRI-ICD to the nucleus, where it contributes to activating specific target
  genes. Other modes of non-canonical TGF-β signaling pathways are also shown. Adapted
  from [,,,,,,,,]. (B) TGF-β signaling can also induce EMT through the activation
  of non-Smad pathways such as Rho GTPase and via the phosphorylation of the polarity
  protein PAR6, leading to cytoskeletal rearrangements and the breakdown of epithelial
  cell junctions, respectively. Adapted from [,,,,].
papertitle: The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis.
reftext: Pramod Mallikarjuna, et al. Biomolecules. 2022 May;12(5):635.
year: '2022'
doi: 10.3390/biom12050635
journal_title: Biomolecules
journal_nlm_ta: Biomolecules
publisher_name: MDPI
keywords: cancer | fibrosis | HIF-1α/2α | hypoxia | Smad | TGF-β | TRAF6
automl_pathway: 0.8983626
figid_alias: PMC9138354__F1
figtype: Figure
organisms_ner:
- Gallus gallus
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
redirect_from: /figures/PMC9138354__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9138354__biomolecules-12-00635-g001.html
  '@type': Dataset
  description: (A) A graphical illustration of canonical (left) and non-canonical
    (right) TGF-β signaling. In canonical TGF-β signaling, TGF-β ligand binds to TGFβRI
    (TβRI) and TGFβRII (TβRII) receptors, resulting in their activation in a hetero-tetrameric
    complex. The intracellular Smad2/3 are next activated by phosphorylation, initiated
    by TGFβRI; pSmad2/3 form a complex with Smad4 and, together with certain transcription
    factors (TF), activate specific targets genes that contain Smad-binding elements
    (SBEs), implicated in growth inhibition, apoptosis, ECM synthesis, and immune
    response. In the non-canonical signaling pathway, TGF-β induces the expression
    of TRAF6 and ubiquitinates it in a Lys63-dependent manner, promoting its catalytic
    activity. TRAF6 then activates TACE and PSEN1, resulting in the proteolytic cleavage
    of TGFβRI, generating the soluble TGFβRI intracellular domain (TGFβRI-ICD/ TβRI-ICD).
    The endosomal adaptor proteins APPL1/APPL2 and intact microtubules are required
    for the translocation of TGFβRI-ICD to the nucleus, where it contributes to activating
    specific target genes. Other modes of non-canonical TGF-β signaling pathways are
    also shown. Adapted from [,,,,,,,,]. (B) TGF-β signaling can also induce EMT through
    the activation of non-Smad pathways such as Rho GTPase and via the phosphorylation
    of the polarity protein PAR6, leading to cytoskeletal rearrangements and the breakdown
    of epithelial cell junctions, respectively. Adapted from [,,,,].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMAD2
  - SMAD4
  - SMAD10
  - SMAD7
  - TV
  - APPL1
  - APPL2
  - ADAM17
  - PSEN1
  - TRAF6
  - TAB1
  - JUN
  - SNAI1
  - MMP2
  - MMP9
  - IL6
  - IL8L1
  - IL8L2
  - RHO
  - OPN1MSW
  - LIMK2
  - ACTB
  - TGFB1
  - TGFB2
  - TGFB3
  - SMAD3
  - EP300
  - SMAD1
  - SMAD5
  - SMAD6
  - SMAD9
  - APLP2
  - MAP3K7
  - NR2C2
  - TGFBR1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CXCL8
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - ROCK1
  - ROCK2
  - LIMK1
  - CFL1
  - CFL2
  - DSTN
  - SEMA6A
  - ACTA1
  - ACTA2
  - ACTC1
  - ACTG1
  - ACTG2
  - PARP1
  - EPRS1
  - SMURF1
  - SMURF2
  - Tgfb1
  - Ltbp1
  - Smad2
  - Smad4
  - Smad7
  - Ep300
  - Appl1
  - Appl2
  - Adam17
  - Psen1
  - Traf6
  - Nr2c2
  - Map3k7
  - Mapk14
  - Jun
  - Snai1
  - Mmp2
  - Mmp9
  - Tgfbr1
  - Mapk8
  - Ecm1
  - Ppp1r13b
  - Nfkb1
  - Il6
  - Cxcl15
  - Pik3r1
  - Rho
  - Rhod
  - Ea2
  - Limk1
  - Sema6a
  - dpp
  - gbb
  - put
  - mav
  - Smox
  - Med
  - Dad
  - sbe
  - osa
  - nej
  - Mad
  - Tace
  - Lst
  - Tak1
  - p38b
  - p38a
  - p38c
  - Jra
  - sna
  - Jag
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - bsk
  - Myb
  - Pi3K21B
  - Taf5
  - Dif
  - dl
  - Rel
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Rok
  - tsr
  - levy
  - COX6AL2
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - He
  - Smurf
---
